CEVA
CEVA, Inc. NASDAQ Listed Nov 1, 2002$49.72
+10.71%
vs $44.91
Mkt Cap $1.2B
52w Low $17.21
99.0% of range
52w High $50.06
50d MA $35.57
200d MA $26.11
P/E (TTM)
-113.0x
EV/EBITDA
—
P/B
3.6x
Debt/Equity
0.1x
ROE
-3.2%
P/FCF
2341.0x
RSI (14)
62.50
ATR (14)
$3.86
Beta
1.53
50d MA
$35.57
200d MA
$26.11
Avg Volume
1.0M
CEVA, Inc. operates as a licensor of wireless connectivity and smart sensing technologies to semiconductor and original equipment manufacturer (OEM) companies worldwide. It designs and licenses various digital signal processors, AI processors, wireless platforms, and complementary software for sensor fusion, image enhancement, computer vision, voice input, and artificial intelligence (AI). The company licenses a family of wireless connectivity and smart sensing technologies, and integrated IP solutions, including DSP-based platforms for 5G baseband processing in mobile, IoT, and infrastructure; imaging and computer vision for any camera-enabled devices; audio/voice/speech and ultra-low power always-on/sensing applications for multiple IoT markets; sensor fusion software and inertial measurement unit solutions for hearables, wearables, AR/VR, PC, robotics, remote controls, and IoT; and wireless IoT for Bluetooth, Wi-Fi 4/5/6/6E, Ultra-wideband (UWB), and NB-IoT. Its technologies are licensed to companies, which design, manufacture, market, and sell application-specific integrated circuits and application-specific standard products to mobile, consumer, automotive, robotics, industrial, aerospace and defense, and IoT companies for incorporation into various end products. The company delivers its DSP cores, platforms, and AI processors in the form of a hardware description language definition; and offers development platforms, software development kits, and software debug tools that facilitate system design, debug, and software development. The company licenses its technology through a direct sales force. The company was formerly known as ParthusCeva, Inc. and changed its name to CEVA, Inc. in December 2003. CEVA, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
15245 Shady Grove Road · Rockville, MD 20850 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | TNS | 0.02 | 0.04 | +100.0% | 36.46 | +0.8% | +1.7% | +2.9% | -0.4% | -3.9% | +0.2% | — |
| Feb 17, 2026 | TNS | 0.18 | 0.18 | +0.0% | 20.45 | -2.2% | -1.8% | -2.1% | -1.1% | -3.6% | +7.3% | — |
| Nov 10, 2025 | TNS | 0.10 | 0.11 | +10.0% | 26.01 | +3.8% | +0.3% | +4.6% | -8.5% | -1.6% | -4.0% | — |
| Aug 11, 2025 | TNS | 0.05 | 0.07 | +40.0% | 21.33 | +0.8% | +10.6% | +3.3% | -1.1% | -3.3% | +1.7% | — |
| May 7, 2025 | TNS | 0.07 | 0.06 | -14.3% | 21.14 | +0.0% | -4.3% | -0.8% | +7.1% | +3.1% | -0.1% | — |
| Feb 13, 2025 | TNS | 0.11 | 0.11 | +0.0% | 34.96 | +2.8% | -0.8% | +3.2% | +0.4% | +1.8% | -5.7% | — |
| Nov 7, 2024 | TNS | 0.09 | 0.14 | +55.6% | 29.34 | +2.2% | -3.6% | -0.4% | -0.6% | -1.1% | -1.1% | — |
| Aug 7, 2024 | TNS | 0.02 | 0.17 | +628.8% | 19.44 | +4.7% | +5.2% | -0.1% | -1.3% | +7.6% | +2.9% | — |
| May 9, 2024 | TNS | -0.01 | -0.05 | -292.5% | 20.25 | -1.4% | -3.2% | -0.7% | +3.1% | +1.6% | -1.2% | — |
| Feb 14, 2024 | TNS | 0.06 | 0.10 | +66.7% | 24.51 | +2.0% | -0.1% | -5.9% | -1.4% | -0.8% | -0.9% | — |
| Nov 8, 2023 | TNS | 0.04 | 0.02 | -44.4% | 19.68 | +1.8% | -4.8% | +6.2% | +0.4% | +10.0% | +1.1% | — |
| Aug 9, 2023 | TNS | 0.08 | -0.02 | -125.0% | 22.06 | -3.1% | -0.4% | -1.6% | -4.1% | -2.2% | -2.3% | — |
| May 10, 2023 | AMC | 0.12 | -0.16 | -233.3% | 21.31 | -1.5% | -1.0% | -0.5% | +3.0% | -1.3% | +0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 | Needham | Initiates | Buy | $55 | $46.03 | $48.60 | +5.6% | +5.3% | -5.5% | -1.9% | +10.7% | — |
| May 8 | JP Morgan | Initiates | Neutral | $30 | $33.72 | $34.22 | +1.5% | +9.6% | -1.4% | +1.7% | +2.9% | -0.4% |
| Mar 12 | Rosenblatt | Maintains | Buy → Buy | — | $19.87 | $19.50 | -1.9% | -7.4% | -0.9% | +2.3% | -0.9% | +0.1% |
| Feb 18 | Rosenblatt | Maintains | Buy → Buy | — | $20.45 | $20.00 | -2.2% | -1.8% | -2.1% | -1.1% | -3.6% | +7.3% |
| Feb 18 | Oppenheimer | Maintains | Outperform → Outperform | — | $20.45 | $20.00 | -2.2% | -1.8% | -2.1% | -1.1% | -3.6% | +7.3% |
| Nov 12 | Barclays | Maintains | Overweight → Overweight | — | $26.08 | $26.80 | +2.8% | +4.6% | -8.5% | -1.6% | -4.0% | -14.5% |
| Nov 11 | Rosenblatt | Maintains | Buy → Buy | — | $26.01 | $26.99 | +3.8% | +0.3% | +4.6% | -8.5% | -1.6% | -4.0% |
| Aug 14 | Rosenblatt | Maintains | Buy → Buy | — | $24.37 | $23.78 | -2.4% | -1.1% | -3.3% | +1.7% | -4.4% | -2.0% |
| May 9 | Oppenheimer | Maintains | Outperform → Outperform | — | $20.24 | $20.51 | +1.3% | -0.8% | +7.1% | +3.1% | -0.1% | -3.7% |
| May 8 | Barclays | Maintains | Overweight → Overweight | — | $21.14 | $21.14 | +0.0% | -4.3% | -0.8% | +7.1% | +3.1% | -0.1% |
| May 8 | Rosenblatt | Maintains | Buy → Buy | — | $21.14 | $21.14 | +0.0% | -4.3% | -0.8% | +7.1% | +3.1% | -0.1% |
| Apr 23 | Rosenblatt | Maintains | Buy → Buy | — | $23.50 | $24.45 | +4.0% | +8.6% | +4.1% | +0.6% | -0.4% | -0.4% |
| Feb 14 | Rosenblatt | Maintains | Buy → Buy | — | $34.96 | $35.95 | +2.8% | -0.8% | +3.2% | +0.4% | +1.8% | -5.7% |
| Feb 14 | Barclays | Maintains | Overweight → Overweight | — | $34.96 | $35.95 | +2.8% | -0.8% | +3.2% | +0.4% | +1.8% | -5.7% |
| Feb 11 | Rosenblatt | Maintains | Buy → Buy | — | $32.73 | $32.13 | -1.8% | -1.8% | -1.3% | +10.2% | -0.8% | +3.2% |
| Dec 23 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $31.11 | $31.20 | +0.3% | +2.3% | +1.4% | +2.8% | -2.4% | -1.0% |
| Nov 8 | Roth MKM | Maintains | Buy → Buy | — | $29.34 | $30.00 | +2.2% | -3.6% | -0.4% | -0.6% | -1.1% | -1.1% |
| Nov 8 | Rosenblatt | Maintains | Buy → Buy | — | $29.34 | $30.00 | +2.2% | -3.6% | -0.4% | -0.6% | -1.1% | -1.1% |
| Oct 31 | Rosenblatt | Maintains | Buy → Buy | — | $24.42 | $24.37 | -0.2% | -4.4% | +1.5% | -0.2% | +1.1% | +5.3% |
| Aug 8 | Roth MKM | Upgrade | Neutral → Buy | — | $19.44 | $20.36 | +4.7% | +5.2% | -0.1% | -1.3% | +7.6% | +2.9% |
| Aug 8 | Oppenheimer | Maintains | Outperform → Outperform | — | $19.44 | $20.36 | +4.7% | +5.2% | -0.1% | -1.3% | +7.6% | +2.9% |
| May 10 | Roth MKM | Maintains | Neutral → Neutral | — | $20.25 | $19.96 | -1.4% | -3.2% | -0.7% | +3.1% | +1.6% | -1.2% |
| Feb 13 | Rosenblatt | Maintains | Buy → Buy | — | $21.93 | $20.84 | -5.0% | -7.9% | +21.4% | -0.1% | -5.9% | -1.4% |
| Dec 7 | Rosenblatt | Maintains | Buy → Buy | — | $21.79 | $22.11 | +1.5% | -1.2% | +0.5% | +5.1% | -2.6% | +1.6% |
| Aug 11 | Barclays | Maintains | Overweight → Overweight | — | $21.97 | $21.64 | -1.5% | -1.6% | -4.1% | -2.2% | -2.3% | +2.9% |
| Aug 10 | Barclays | Maintains | Overweight → Overweight | — | $22.06 | $21.37 | -3.1% | -0.4% | -1.6% | -4.1% | -2.2% | -2.3% |
| Aug 10 | Rosenblatt | Maintains | Buy → Buy | — | $22.06 | $21.37 | -3.1% | -0.4% | -1.6% | -4.1% | -2.2% | -2.3% |
| Aug 10 | Roth MKM | Downgrade | Buy → Neutral | — | $22.06 | $21.37 | -3.1% | -0.4% | -1.6% | -4.1% | -2.2% | -2.3% |
| Aug 10 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $22.06 | $21.37 | -3.1% | -0.4% | -1.6% | -4.1% | -2.2% | -2.3% |
| May 11 | Barclays | Maintains | Overweight → Overweight | — | $21.31 | $21.00 | -1.5% | -1.0% | -0.5% | +3.0% | -1.3% | +0.6% |
| May 11 | TD Cowen | Maintains | Outperform → Outperform | — | $21.31 | $21.00 | -1.5% | -1.0% | -0.5% | +3.0% | -1.3% | +0.6% |
| May 11 | Roth MKM | Maintains | Buy → Buy | — | $21.31 | $21.00 | -1.5% | -1.0% | -0.5% | +3.0% | -1.3% | +0.6% |
| May 11 | Oppenheimer | Maintains | Outperform → Outperform | — | $21.31 | $21.00 | -1.5% | -1.0% | -0.5% | +3.0% | -1.3% | +0.6% |
| Feb 17 | Barclays | Maintains | Overweight → Overweight | — | $32.65 | $32.97 | +1.0% | +1.1% | -3.1% | -0.7% | +1.4% | -1.7% |
| Feb 16 | TD Cowen | Maintains | Outperform → Outperform | — | $34.66 | $34.98 | +0.9% | -5.8% | +1.1% | -3.1% | -0.7% | +1.4% |
| Nov 11 | Barclays | Maintains | Overweight → Overweight | — | $28.19 | $28.00 | -0.7% | +0.4% | -1.0% | +3.6% | -2.3% | +0.4% |
| Nov 10 | Rosenblatt | Maintains | Buy → Buy | — | $26.05 | $27.38 | +5.1% | +8.2% | +0.4% | -1.0% | +3.6% | -2.3% |
| Feb 16 | Rosenblatt | Upgrade | Neutral → Buy | — | $40.00 | $41.24 | +3.1% | +4.8% | -3.9% | -0.3% | -2.7% | -2.4% |
| May 11 | Barclays | Upgrade | Equal Weight → Overweight | — | $42.40 | $42.25 | -0.4% | +7.9% | -7.1% | -3.3% | +4.1% | -0.0% |
| May 11 | Northland Capital Markets | Upgrade | Market Perform → Outperform | — | $42.40 | $42.25 | -0.4% | +7.9% | -7.1% | -3.3% | +4.1% | -0.0% |
| Feb 17 | Roth Capital | Maintains | Buy → Buy | — | $74.11 | $73.00 | -1.5% | -3.8% | -5.9% | +4.7% | -4.4% | -1.3% |
| Sep 21 | Northland Capital Markets | Upgrade | Market Perform → Outperform | — | $36.86 | $37.00 | +0.4% | +0.9% | +1.7% | -3.1% | +1.7% | +1.1% |
| Mar 30 | Northland Capital Markets | Upgrade | Market Perform → Outperform | — | $21.05 | $21.73 | +3.2% | +12.8% | +5.0% | -1.4% | +5.9% | -1.2% |
| Mar 30 | Northland Securities | Upgrade | Market Perform → Outperform | — | $21.05 | $21.73 | +3.2% | +12.8% | +5.0% | -1.4% | +5.9% | -1.2% |
| Aug 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $31.40 | $32.15 | +2.4% | -3.2% | +2.3% | +3.0% | -1.8% | -1.9% |
| Apr 17 | Exane BNP Paribas | Downgrade | Outperform → Neutral | — | $27.78 | $25.07 | -9.8% | -13.6% | -2.9% | +2.1% | +1.0% | +2.5% |
| Feb 14 | Northland Securities | Downgrade | Outperform → Market Perform | — | $28.59 | $27.41 | -4.1% | -3.3% | +4.6% | -1.2% | +0.2% | +0.2% |
| Feb 14 | Northland Capital Markets | Downgrade | Outperform → Market Perform | — | $28.59 | $27.41 | -4.1% | -3.3% | +4.6% | -1.2% | +0.2% | +0.2% |
| Oct 16 | Canaccord Genuity | Maintains | Buy → Buy | — | $24.96 | $25.85 | +3.6% | +9.6% | -1.3% | -3.1% | -1.2% | -0.8% |
| Aug 8 | Barclays | Maintains | Overweight → Overweight | — | $27.60 | $27.40 | -0.7% | +3.4% | +4.0% | -0.3% | -1.0% | +1.0% |
No insider trades available.
8-K
CEVA, Inc. -- 8-K Filing
Jun 3
8-K · 2.02
!! High
CEVA, Inc. -- 8-K 2.02: Earnings Results
May 11
8-K · 5.02
!!! Very High
CEVA Inc. -- 8-K 5.02: Executive Change
CEVA Inc. loses executive Sven-Christer Nilsson as he declines re-election, potentially signaling leadership transition and uncertainty for investors monitoring the semiconductor IP company's strategic direction.
Apr 20
8-K
CEVA Inc. -- 8-K Filing
CEVA Inc. reported fourth quarter and full year 2025 financial results, with CFO Yaniv Arieli disclosing earnings that investors should evaluate for revenue trends and profitability metrics.
Feb 17
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 3,746,444 | $81M | Added | Dec 2025 |
| 2 | Vanguard Portfolio Management Llc | 1,134,502 | $21M | New | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 1,133,499 | $21M | New | Mar 2026 |
| 4 | Neuberger Berman Group Llc | 1,008,061 | $19M | Added | Mar 2026 |
| 5 | Acadian Asset Management Llc | 758,319 | $14M | Added | Mar 2026 |
| 6 | Point72 Asset Management | 607,434 | $11M | Reduced | Mar 2026 |
| 7 | D.e. Shaw & Co | 470,387 | $9M | Added | Mar 2026 |
| 8 | Rice Hall James & Associates, Llc | 403,756 | $9M | — | Dec 2025 |
| 9 | Two Sigma Investments, Lp | 302,834 | $6M | Added | Mar 2026 |
| 10 | Jane Street Group, Llc | 253,967 | $5M | Added | Dec 2025 |
| 11 | Capitolis Liquid Global Markets Llc | 261,400 | $5M | — | Mar 2026 |
| 12 | Millennium Management | 255,826 | $5M | Reduced | Mar 2026 |
| 13 | Northern Trust Corp | 250,750 | $5M | Added | Mar 2026 |
| 14 | Needham Investment Management Llc | 230,000 | $4M | Added | Mar 2026 |
| 15 | Nuveen, Llc | 219,371 | $4M | Added | Mar 2026 |
| 16 | Algert Global Llc | 199,217 | $4M | New | Mar 2026 |
| 17 | Dnb Asset Management As | 152,741 | $3M | Added | Mar 2026 |
| 18 | Silverberg Bernstein Capital Management Llc | 140,617 | $3M | — | Mar 2026 |
| 19 | Hrt Financial Lp | 123,249 | $2M | Reduced | Mar 2026 |
| 20 | Jpmorgan Chase & Co | 116,395 | $2M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.21B
Enterprise Value
$1.00B
P/E (TTM)
-113.00x
Forward P/E
99.30x
PEG Ratio
-2.60x
P/B
3.59x
P/S
11.02x
P/FCF
2340.98x
EV/EBITDA
—
Shares Out
24.3M
Financials (TTM)
Revenue
$109.6M
Net Income
-$10.6M
EBITDA
-$554K
Free Cash Flow
$516K
Op Cash Flow
$3.5M
EPS Basic
$-0.44
EPS Diluted
$-0.44
EPS Forward
$0.50
Gross Margin
87.1%
Op Margin
-10.3%
Net Margin
-9.7%
Balance Sheet
Total Assets
$388.3M
Total Liab.
$51.8M
Total Equity
$336.5M
Cash
$222.0M
LT Debt
$14.4M
Book Value/Sh
$13.85
Debt/Equity
0.09x
Current Ratio
9.93
Quick Ratio
9.93
Returns & Growth
ROE
-3.2%
ROA
-2.7%
ROIC
-3.1%
Rev Growth YoY
+2.5%
EPS Growth YoY
-18.9%
Price Returns
2W
+5.2%
1M
+30.9%
3M
+91.7%
6M
+85.2%
12M
+113.1%
Technicals
52W High
$50.06
52W Low
$17.21
50d MA
$35.57
200d MA
$26.11
RSI (14)
62.50
ATR (14)
$3.86
Beta
1.53
Avg Volume
1.0M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$29.33
High
$30.00
Low
$28.00
Median
$30.00
Data updated apr 25, 2026 12:50am
· Source: financialmodelingprep.com